1-[4-[3-[4-[Bis (4-fluorophenyl) hydroxymethyl]-1-piperidinyl] propoxy]-3]-methoxyphenyl] ethanone (AHR-5333): A selective human blood neutrophil 5-lipoxygenase inhibitor
- 30 September 1989
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 38 (4) , 473-496
- https://doi.org/10.1016/0090-6980(89)90130-5
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Effect of AHR-5333 on flea antigen extract-induced skin reactions in flea-allergic dogsJournal of Veterinary Pharmacology and Therapeutics, 1988
- Characterization of leukotriene C4 synthetase in mouse peritoneal exudate cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- 169 AHR-5333, a new antiallergy compound. I. In vivo inhibition of immediate hypersensitivity modelsJournal of Allergy and Clinical Immunology, 1988
- Eosinophil-rich human polymorphonuclear leukocyte preparations characteristically release leukotriene C4 on ionophore A23187 challengeJournal of Allergy and Clinical Immunology, 1984
- The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.Journal of Clinical Investigation, 1984
- Leukotriene generation by eosinophils.The Journal of Experimental Medicine, 1982
- Leukotrience C4: isolation from human polymorphonuclear leukocytesFEBS Letters, 1980
- Biological profile of Ieukotrienes C4 and D4Acta Physiologica Scandinavica, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976